Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry

被引:12
作者
Zubaid, Mohammad [1 ]
Khraishah, Haitham [2 ]
Alahmad, Barrak [3 ]
Rashed, Wafa [4 ]
Ridha, Mustafa [5 ]
Alenezi, Fahad [6 ]
Aljarralah, Mohamad [7 ]
Al-Marri, Khalid [8 ]
Almutairi, Mohammad [9 ]
Althalji, Khalid [6 ]
Alfaddagh, Abdulhamied [10 ]
机构
[1] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, TH Chan Sch Publ Hlth, Environm Hlth Dept, Boston, MA 02115 USA
[4] Minist Hlth, Dept Med, Div Cardiol, Mubarak Alkabeer Hosp, Kuwait, Kuwait
[5] Minist Hlth, Dept Cardiol, Salman Aldabous Cardiac Ctr, Kuwait, Kuwait
[6] Minist Hlth, Dept Med, Div Cardiol, Alfarwaniya Hosp, Kuwait, Kuwait
[7] Minist Hlth, Dept Cardiol, Sabah Alahmad Cardiac Ctr, Kuwait, Kuwait
[8] Minist Hlth, Dept Cardiol, Chest Dis Hosp, Kuwait, Kuwait
[9] Aljahra Hosp, Dept Med, Div Cardiol, Kuwait, Kuwait
[10] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
来源
ANNALS OF GLOBAL HEALTH | 2020年 / 86卷 / 01期
关键词
GULF REGISTRY; TASK-FORCE; REPERFUSION; OUTCOMES; DELAYS; FIBRINOLYSIS; GUIDELINES; EXPERIENCE; TRENDS; PCI;
D O I
10.5334/aogh.2632
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in the real-world is unclear. Objectives: To compare the effectiveness of pharmacoinvasive strategy versus primary PCI using a nationwide prospective registry of STEMI patients. Methods: We examined 936 STEMI patients from the reperfusion in ST-elevation myocardial infarction in Kuwait (REPERFUSE Kuwait) registry who underwent either primary PCI or pharmacoinvasive reperfusion. A composite outcome was measured based on death, congestive heart failure, reinfarction or stroke prospectively ascertained during hospital stay and up to one-year follow-up. The association between reperfusion strategy and the composite outcome was assessed using multivariate regression and Poisson proportional hazard model. Results: Compared to the pharmacoinvasive group, those undergoing primary PCI had higher Killip class on presentation and required more blood transfusions during hospitalization. There was no significant difference between primary PCI and pharmacoinvasive strategy with regards to the incidence of the composite outcome during the in-hospital period (RR = 1.0; 95% CI 0.98-1.02; p = 0.96) after adjustment for possible confounders. Over one-year follow-up, the survival of the two groups was not different (p = 0.66). The incidence of major bleeding was similar in both groups. Conclusion: STEMI patients treated with a pharmacoinvasive strategy have comparable outcomes to those treated with primary PCI with no increased risk of major bleeding. These real-world data support the use of a pharmacoinvasive strategy when primary PCI cannot be achieved in a timely fashion.
引用
收藏
页数:10
相关论文
共 50 条
[21]   Outcomes of Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients With Previous Coronary Bypass Surgery [J].
Kohl, Louis P. ;
Garberich, Ross F. ;
Yang, Hannah ;
Sharkey, Scott W. ;
Burke, M. Nicholas ;
Lips, Daniel L. ;
Hildebrandt, David A. ;
Larson, David M. ;
Henry, Timothy D. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (09) :981-987
[22]   Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST-segment elevation at the National Institute of Cardiology (PHASE-MX) [J].
Baeza-Herrera, Luis A. ;
Araiza-Garaygordobil, Diego ;
Gopar-Nieto, Rodrigo ;
Raymundo-Martinez, Grecia, I ;
Loaisiga-Saenz, Arnoldo ;
Villalobos-Flores, Abraham ;
Martinez-Ramos, Manuel ;
Torres-Araujo, Laura, V ;
Pohls-Vazquez, Ricardo ;
Luna-Herbert, Abraham ;
Alonso-Vazquez, Arturo ;
Delgado-Cruz, Itzel, V ;
Cabello-Lopez, Alejandro ;
Martinez-Amezcua, Pablo ;
Arias-Mendoza, Maria A. .
ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (02) :137-141
[23]   Assessment of the efficacy of primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction based on the ECG analysis [J].
Madzitow, Hikmat H. ;
Alimow, Donyor A. .
POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2011, 7 (04) :292-296
[24]   Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease [J].
Cui, Kongyong ;
Lyu, Shuzheng ;
Song, Xiantao ;
Liu, Hong ;
Yuan, Fei ;
Xu, Feng ;
Zhang, Min ;
Wang, Wei ;
Zhang, Mingduo ;
Zhang, Dongfeng ;
Tian, Jinfan .
AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (03) :334-342
[25]   Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock [J].
Kochar, Ajar ;
Al-Khalidi, Hussein R. ;
Hansen, Steen M. ;
Shavadia, Jay S. ;
Roettig, Mayme L. ;
Fordyce, Christopher B. ;
Doerfler, Shannon ;
Gersh, Bernard J. ;
Henry, Timothy D. ;
Berger, Peter B. ;
Jollis, James G. ;
Granger, Christopher B. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (18) :1824-1833
[26]   A Risk Score for No Reflow in Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention [J].
Wang, Jin-Wen ;
Zhou, Zi-Qiang ;
Chen, Yun-Dai ;
Wang, Chang-Hua ;
Zhu, Xiao-ling .
CLINICAL CARDIOLOGY, 2015, 38 (04) :208-215
[27]   Results of the Croatian Primary Percutaneous Coronary Intervention Network for Patients With ST-Segment Elevation Acute Myocardial Infarction [J].
Heitzler, Vjeran Nikolic ;
Babic, Zdravko ;
Milicic, Davor ;
Bergovec, Mijo ;
Raguz, Miroslav ;
Mirat, Jure ;
Strozzi, Maja ;
Plazonic, Zeljko ;
Giunio, Lovel ;
Steiner, Robert ;
Starcevic, Boris ;
Vukovic, Ivica .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (09) :1261-1267
[28]   Fibrinolysis vs. primary percutaneous coronary intervention for ST-segment elevation myocardial a infarction cardiogenic shock [J].
Vallabhajosyula, Saraschandra ;
Verghese, Dhiran ;
Bell, Malcolm R. ;
Murphree, Dennis H. ;
Cheungpasitporn, Wisit ;
Miller, Paul Elliott ;
Dunlay, Shannon M. ;
Prasad, Abhiram ;
Sandhu, Gurpreet S. ;
Gulati, Rajiv ;
Singh, Mandeep ;
Lerman, Amir ;
Gersh, Bernard J. ;
Holmes, David R., Jr. ;
Barsness, Gregory W. .
ESC HEART FAILURE, 2021, 8 (03) :2025-2035
[29]   Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice Insights From the Vital Heart Response Registry [J].
Bainey, Kevin R. ;
Armstrong, Paul W. ;
Zheng, Yinggan ;
Brass, Neil ;
Tyrrell, Benjamin D. ;
Leung, Raymond ;
Westerhout, Cynthia M. ;
Welsh, Robert C. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (10)
[30]   Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock [J].
Damluji, Abdulla A. ;
Bandeen-Roche, Karen ;
Berkower, Carol ;
Boyd, Cynthia M. ;
Al-Damluji, Mohammed S. ;
Cohen, Mauricio G. ;
Forman, Daniel E. ;
Chaudhary, Rahul ;
Gerstenblith, Gary ;
Walston, Jeremy D. ;
Resar, Jon R. ;
Moscucci, Mauro .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (15) :1890-1900